Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when TLS files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TLS TELOS CORP 8-K

Telos CEO John Wood returns from medical leave, resumes full duties as President and Chairman

Filed May 28, 2026 · Period ending May 28, 2026 · ~1 min read

3 key changes 1 high relevance 1 section

Key Changes

  • high

    CEO John B. Wood returned from medical leave on May 28, 2026, resuming all responsibilities as President, Chief Executive Officer, and Chairman of the Board.

  • medium

    Interim leadership structure ended with four executives returning to regular roles: Mark Griffin, Mark Bendza, and Hutch Robbins ceased sharing CEO duties, while Fred Schaufeld stepped down as interim Chairman.

  • low

    No changes were made to executive compensation in connection with Wood's return to full-time duties.

Summary

Telos Corporation's CEO John B. Wood has returned to full-time leadership after a medical leave of absence that began in late April 2026. The company had implemented an interim management structure where three senior executives shared CEO responsibilities while board member Fred Schaufeld served as interim Chairman. That temporary arrangement, which lasted an undisclosed amount one month, has now been dissolved.

For shareholders, this represents a return to normal operations and governance structure. Leadership continuity is restored with the CEO back at the helm, eliminating any uncertainty about the company's direction during the interim period. The brief duration of the leave and smooth transition suggest the medical issue was successfully resolved.

Investors should watch for any operational updates or strategic announcements in coming weeks as Wood reassumes control. The next earnings call or investor presentation will be the first opportunity to hear directly from the CEO about the company's priorities and performance during his absence.

Section-by-Section Diff

Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation

~300 words

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.

3 Added
Added CEO return from medical leave high

Added in current filing · verify on EDGAR →

Effective May 28, 2026, John B. Wood, President, Chief Executive Officer and Chairman of the Board of Telos Corporation (the “Company”), has returned from his medical leave of absence and has resumed his full duties and responsibilities.

John B. Wood has returned to his full-time role as President, CEO, and Chairman after a medical leave of absence. The interim leadership arrangements that were in place during his absence have now terminated, with four executives who temporarily shared CEO responsibilities returning to their regular roles.

Added Termination of interim leadership medium

Added in current filing · verify on EDGAR →

In connection with Mr. Wood’s return, the interim arrangements previously announced by the Company on April 29, 2026 have terminated. Accordingly, Mark Griffin, Executive Vice President, Security Solutions, Mark Bendza, Executive Vice President and Chief Financial Officer, and Hutch Robbins, Executive Vice President and General Counsel, have ceased exercising the responsibilities of the Chief Executive Officer on an interim basis, and Fred Schaufeld has ceased serving as Chairman of the Board on an interim basis, with Mr. Wood resuming as Chairman.

The interim leadership structure announced on April 29, 2026 has ended. Three executives who shared CEO duties and one who served as interim Chairman have returned to their regular positions. This restores the company's normal governance structure.

Show 1 minor / wording change
Added No compensation changes low

Added in current filing · verify on EDGAR →

No compensatory arrangements were entered into or modified in connection with Mr. Wood’s return to his duties.

The company confirms that no changes were made to executive compensation as part of the CEO's return from medical leave.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · May 29, 2026 · How we verify